BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6208720)

  • 21. Prurigo nodularis and Hashimoto thyroiditis.
    Rishi R; Ringwala S; Tracy J; Fatteh S
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):673-4. PubMed ID: 25446192
    [No Abstract]   [Full Text] [Related]  

  • 22. Thalidomide neurotoxicity.
    Clemmensen OJ; Olsen PZ; Andersen KE
    Arch Dermatol; 1984 Mar; 120(3):338-41. PubMed ID: 6703734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of prurigo nodularis with topical capsaicin.
    Ständer S; Luger T; Metze D
    J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An observational analysis of low-dose thalidomide in recalcitrant prurigo nodularis.
    Sardana K; Gupta A; Sinha S
    Clin Exp Dermatol; 2020 Jan; 45(1):92-96. PubMed ID: 31132160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo measurements of iron, copper and zinc in the skin of prurigo nodularis patients treated with thalidomide.
    Sheskin J; Gorodetzky R; Loewinger E; Weinreb A
    Dermatologica; 1981; 162(2):86-90. PubMed ID: 7250458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case series of 48 patients treated with thalidomide.
    Doherty SD; Hsu S
    J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prurigo nodularis and photosensitivity in AIDS: treatment with thalidomide.
    Berger TG; Hoffman C; Thieberg MD
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):837-8. PubMed ID: 7593791
    [No Abstract]   [Full Text] [Related]  

  • 28. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
    Plamondon S; Ng SC; Kamm MA
    Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of AIDS-associated prurigo nodularis with thalidomide.
    Herranz P; Pizarro A; De Lucas R; Arribas JR; García-Tobaruela A; Peña JM; Casado M
    Clin Exp Dermatol; 1998 Sep; 23(5):233-5. PubMed ID: 10233821
    [No Abstract]   [Full Text] [Related]  

  • 30. Thalidomide: an experience in therapeutic outcome and adverse reactions.
    Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
    J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical vitamin D3 (tacalcitol) for steroid-resistant prurigo.
    Katayama I; Miyazaki Y; Nishioka K
    Br J Dermatol; 1996 Aug; 135(2):237-40. PubMed ID: 8881666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Apremilast in Patients with Prurigo Nodularis: A Proof-of-concept Study.
    Todberg T; Skov L; Simonsen S; Kainu K; Zachariae C
    Acta Derm Venereol; 2020 Apr; 100(8):adv00118. PubMed ID: 32189005
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of prurigo nodularis with thalidomide: a case report and review of the literature.
    Alfadley A; Al-Hawsawi K; Thestrup-Pedersen K; Al-Aboud K
    Int J Dermatol; 2003 May; 42(5):372-5. PubMed ID: 12755975
    [No Abstract]   [Full Text] [Related]  

  • 34. [Should thalidomide be rehabilitated?].
    Belaube P; Garcin G; Marchand JP; Privat Y
    Sem Hop; 1983 Dec; 59(45):3101-4. PubMed ID: 6320398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immune effects of thalidomide in actinic prurigo.
    Bernal JE; Duran MM; Londoño F; Umaña A
    Int J Dermatol; 1992 Aug; 31(8):599-600. PubMed ID: 1428460
    [No Abstract]   [Full Text] [Related]  

  • 36. Thalidomide in actinic prurigo.
    Lovell CR; Hawk JL; Calnan CD; Magnus IA
    Br J Dermatol; 1983 Apr; 108(4):467-71. PubMed ID: 6838772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide for the treatment of chronic refractory prurigo nodularis.
    Aguh C; Kwatra SG; He A; Okoye GA
    Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide and its dermatologic uses.
    Paghdal KV; Schwartz R
    Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide experience of a major Australian teaching hospital.
    Crouch RB; Foley PA; Ng JC; Baker CS
    Australas J Dermatol; 2002 Nov; 43(4):278-84. PubMed ID: 12423435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small bowel deposition of crystals associated with the use of clofazimine (Lamprene) in the treatment of prurigo nodularis.
    Belaube P; Devaux J; Pizzi M; Boutboul R; Privat Y
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):328-30. PubMed ID: 6685693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.